Literature DB >> 26415369

Tumor Infiltrating T Lymphocytes and Apoptosis in Colorectal Cancer.

Manal M S Youssef, Emma C Paish, J Clifford Murray, Naglaa M Farag, Khaled Saleh, I O Ellis.   

Abstract

Dysfunction of the immune system in colorectal cancer (CRC) can be due to a number of reasons including apoptosis of tumour infiltrating lymphocytes (TILs). The aims of this study was to investigate TILs in colorectal cancer and characterize apoptosis of TILs using terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay for detecting DNA fragments. We used monoclonal antibodies (mAbs) to T lymphocytes to detect TILs and double immunohistochemistry to assess apoptosis. T lymphocytes were detected in the immune infiltrate in CRC. TUNEL staining disclosed a high level of cell death among TILs. Apoptosis of T lymphocytes showed significant correlation with Dukes' stage (P = 0.02), lymphatic metastasis (P = 0.03), vascular metastasis (P = 0.01), lymph node metastasis (P = 0.02) and age of patient (P = 0.01). In conclusion, CRC may elude immunological surveillance by inducing apoptosis of TILs.

Entities:  

Mesh:

Year:  2015        PMID: 26415369

Source DB:  PubMed          Journal:  Egypt J Immunol


  3 in total

1.  Tumor-infiltrating lymphocytes in primary tumors of colorectal cancer and their metastases.

Authors:  Katarzyna Jakubowska; Mariusz Koda; Wojciech Kisielewski; Luiza Kańczuga-Koda; Waldemar Famulski
Journal:  Exp Ther Med       Date:  2019-10-30       Impact factor: 2.447

2.  PD-L1 Expression Level Displays a Positive Correlation with Immune Response in Pancreatic Cancer.

Authors:  Lei Zhao; Yaming Cao
Journal:  Dis Markers       Date:  2020-09-25       Impact factor: 3.434

3.  Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors.

Authors:  Juan Carlos Andreu-Ballester; Lorena Galindo-Regal; Julia Hidalgo-Coloma; Carmen Cuéllar; Carlos García-Ballesteros; Carolina Hurtado; Natalia Uribe; María Del Carmen Martín; Ana Isabel Jiménez; Francisca López-Chuliá; Antonio Llombart-Cussac
Journal:  PLoS One       Date:  2020-12-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.